CDC’s Recommendations for Pfizer-BioNTech COVID-19 Vaccine Children 5–11

0
11

The Centers for Disease Control and Prevention will provide an overview of its recommendations and clinical considerations for administering the Pfizer-BioNTech COVID-19 vaccination primary series in children aged 5–11 years old.

LEAVE A REPLY

Please enter your comment!
Please enter your name here